Senti Biosciences Holdings
SNTI
45 hedge funds and large institutions have $180M invested in Senti Biosciences Holdings in 2022 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 6 increasing their positions, 13 reducing their positions, and 8 closing their positions.
38% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 8
7% more funds holding
Funds holding: 42 → 45 (+3)
3% more capital invested
Capital invested by funds: $175M → $180M (+$4.61M)
0.19% more ownership
Funds ownership: 7.5% → 7.69% (+0.19%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
54% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 13
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FTCM
First Trust Capital Management
Chicago,
Illinois
|
+$7.68M |
| 2 |
WCMNY
Westchester Capital Management (New York)
Valhalla,
New York
|
+$5.4M |
| 3 |
Marshall Wace
London,
United Kingdom
|
+$4.46M |
| 4 |
Millennium Management
New York
|
+$4.22M |
| 5 |
IPCP
Iron Park Capital Partners
New York
|
+$2.23M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$7.63M |
| 2 |
Morgan Stanley
New York
|
-$5.08M |
| 3 |
Blackstone Inc
New York
|
-$2.96M |
| 4 |
CAC
Cowen and Company
New York
|
-$1.81M |
| 5 |
NIP
Nicholas Investment Partners
Rancho Santa Fe,
California
|
-$1.73M |
SNTI Hedge Fund Activity: Q1 2022 in Review
45 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Senti Biosciences Holdings (SNTI) for Q1 2022, worth a combined $180M — up 2.6% from $175M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new SNTI positions and 8 closed out — a net gain of 3 holders — while 6 added to existing stakes and 13 trimmed.
The largest buyer was First Trust Capital Management, opening a new position worth an estimated $7.68M. The largest seller was JP Morgan Chase, cutting an estimated $7.63M.
- 45 institutional investors held Senti Biosciences Holdings (SNTI) as of Q1 2022, up from 42 in Q4 2021.
- Funds reported $180M of Senti Biosciences Holdings stock for Q1 2022, up 2.6% quarter-over-quarter.
- 11 funds opened new Senti Biosciences Holdings positions in Q1 2022 and 8 closed out, a net change of +3 holders.
- The largest Senti Biosciences Holdings buyer in Q1 2022 was First Trust Capital Management, an estimated $7.68M added.
- The largest Senti Biosciences Holdings seller in Q1 2022 was JP Morgan Chase, an estimated $7.63M sold.
Based on aggregated 13F filings for Q1 2022.